why choose us

Clinical Trials Search

Showing 16,950 of 132,963 result(s)
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC

Status: Completed

Condition: Metastatic Castration-resistant Prostate Cancer

Interventions: ONC-392 will be given at 10 mg;kg IV infusion, once every 28 days, for up to 13 doses.

Date: 2022-12-26

Colloid Infusion for Optimal Outcomes In Non-cardiac Surgery (COIN Trial)

Status: Completed

Condition: Postoperative Complications

Interventions: Intravenous Hydroxyethyl Starch 130;0.4 and Electrolyte injection of 5ml;kg before induction of general anesthesia

Date: 2022-12-26

Barotrauma in Hyperbaric Oxygen Therapy

Status: Completed

Condition: Barotrauma

Interventions: One-time 60mg dose given orally between 45-120 minutes prior to hyperbaric oxygen therapy

Date: 2022-12-26

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

Status: COMPLETED

Condition: Psoriasis

Interventions: VTAMA® (tapinarof) Cream 1% applied topically once daily

Date: 2022-12-26

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1;PD-L1 Inhibitors

Status: Completed

Condition: Non Small Cell Lung Cancer

Interventions: Gotistobart will be administrated through IV infusion over 60 minutes, once every 21 days in assigned dose.

Date: 2022-12-26

The Effect of Video Education to the Febrile Child on the Knowledge, Attitudes and Behaviors of the Parents.

Status: Completed

Condition: Fever
Child, Only
Approach-Approach Conflict
Parents

Interventions: Interventional

Date: 2022-12-26

Microstream® Capnography in Endobronchial Ultrasonography Applications Under Sedation

Status: Active, not recruiting

Condition: Capnography
Endobronchial Ultrasound

Interventions: Interventional

Date: 2022-12-26

The Effect of Using Virtual Reality Glasses on Pain During Fistula Cannulation in Hemodialysis Patients

Status: Completed

Condition: Hemodialysis Patients

Interventions: Interventional

Date: 2022-12-26

Impact of 3D Intraoral Scanning on Postsurgical Evaluation of Mandibular Third Molar Surgery

Status: Completed

Condition: Third Molar Surgery
Impacted Third Molar Tooth

Interventions: Interventional

Date: 2022-12-26

Expanded Access to RBS2418

Status:

Condition: Expanded Access

Interventions: Drug: RBS2418
RBS2418 will be administered orally at 200 mg two times per day (BID).

Date: 2022-12-26